Enifer secures €12 million grant to build a first-of-its-kind mycoprotein ingredient factory
The Finnish biotech startup is gearing up the production of its proprietary PEKILO® mycoprotein. Once fully running, the new factory will have a production capacity of around 3 million kilograms a year – equal to the amount of protein from 30,000 cows but with at least 20 times lower carbon emissions.
Business Finland has conditionally approved a recycling and reuse investment grant of more than €12 million for biotech startup Enifer to build its first commercial-scale PEKILO®
The commercial-scale factory will produce Enifer’s unique PEKILO® mycoprotein ingredients, which are made using fungal fermentation. The PEKILO® fermentation process has a long legacy – it was originally developed by Finnish forest industry engineers in the 1970s. As the world’s first commercial mycoprotein production process from 1975 to 1991, it converted forest industry by-products into sustainable feed protein for the domestic market.
Enifer has taken the original process many steps further and developed a food-grade ingredient based on the original PEKILO® technology. The product is a protein- and fiber-rich powder with a neutral taste and color that can be used in a similar way to plant-based proteins in the food industry today. The company is expecting to file for regulatory approval of its food-grade ingredient during the first half of 2024.
The new facility will have a production capacity of 3 million kilograms a year of sustainable, locally sourced protein – roughly equivalent to the protein content of meat from 30,000 cows but with at least 20 times lower carbon emissions and considerably lower water and land use. The factory is currently projected to cost €30M to build and is expected to be completed by the end of 2025, with production ramp-up occurring in 2026. Enifer is currently undertaking basic engineering of the facility together with design and engineering company AFRY. The facility will be built in the Uusimaa region, with an announcement on the location expected during Q1/2024.